TCL Archive Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala June 18, 1993
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
